Bookmarks Share Print

NASH Information

Globally, fatty liver disease affects 15 to 40% of the general population. NASH affects 10-20% of patients with fatty liver and incidence increases with weight gain. Although having fat in the liver is not normal, it usually causes no problems or permanent damage. If fatty liver is suspected based on blood test results or scans of the liver, this problem is called nonalcoholic fatty liver disease (NAFLD). When a liver biopsy is performed, it will show that some people have NASH while others simply have fatty liver. There are currently no medicines available to treat patients with NASH.

Learn more about NASH, including commonly used terms, below:

NASH FAQs

Definition, causes and information on the study medication.

Glossary of NASH terminology

A list of common terms pertaining to NASH with definitions.

NASH Eligibility

See if you may be eligible to participate in the study. 

 

NASH informational video

 

Additional information about NASH can be found here:

National Institute of Diabetes and Digestive and Kidney Diseases: www.niddk.nih.gov

National Library of Medicine: www.nlm.nih.gov/medlineplus/healthtopics.html

The American Association for the Study of Liver Diseases: www.aasld.org

The American Liver Foundation: www.liverfoundation.org

Clinicaltrials.gov: www.clinicaltrials.gov